The New England Journal of Medicine (Singhal, U., et al.) 11.04.2023, published a perspective article, “Modernizing Federal Oversight of Laboratory-Developed Tests — Toward Safety, Validity, and Utility.” In this article authors describe the current Federal oversight processes of Laboratory-developed tests (LDTs) and how it has evolved over time. They describe the potential harms that unregulated LDTs may have on patients as well as the potential obstacles that laboratories may face with innovation if regulations are too restrictive.
The section focuses on article about federal legislation concerning Lyme and tick-borne diseases issues introduced into and passed by Congress.
The Senate has just released the 2023 Omnibus Appropriations Bill. The Explanatory Statement includes, under Emerging & Zoonotic Infectious Diseases, $26M for Lyme, as well as much language on Lyme/VBD. It also incorporates activities in HR117-403 which includes Lyme language LDA provided to Congress.
New Hampshire House Bill 1022, “permitting pharmacists to dispense the drug ivermectin by means of a standing order,” was introduced and amended on March 17, 2022. HB1022 was Referred to […]
May 27, 2021 –Today, during May Lyme Disease Awareness Month, Congressman Christopher Smith (NJ-4-R) introduced a bill which could change the way our children with Lyme disease have been treated […]
In my administrative role in the Jackson Township schools, I was responsible for everything in the school district concerning students and then some. I was in charge of special education, student attendance, guidance, and health services among other areas. I had a unique view of the overall functioning of both regular education, and special education, as well as the various points at which they met. Little did I know when I first came to Jackson Township that it was the tick capitol of New Jersey. We literally had hundreds of students with various stages of Lyme Disease on any given day.
News from Congressman Chris Smith website: The House of Representatives passed an amendment authored by Rep. Chris Smith (R-NJ) which increases Lyme disease research funding by $4 million, for a […]
In a complex government process, the Tick Act–a bill that provides funding for Vector-Borne Diseases including Lyme– was not fully funded according to the Committee report on HHS. The Committee […]
Update: The Bill and passed amendments such as this one (below) has now moved to the conference committee where the House and Senate will work to decide what language goes into the final product. The LDA provided input into the amendment language and has been working to get Senators to champion the inclusion of this GAO Investigation Amendment into the final bill.
Rep. Chris Smith Rep. Collin Peterson ISSUE At this time the Lyme Disease Association, Inc. is asking you to contact your Congress Member to ask him/her to sign on to […]
The White House released the Fiscal Year 2021 budget proposal which includes a $14 million increase compared to the 2020 enacted level that focuses on tick-borne diseases. Excerpts from Budget […]